EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial).
Saved in:
| Title: | EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial). |
|---|---|
| Authors: | Hennessy MA; Cancer Research @UCC, College of Medicine & Health, University College Cork, Cork, Ireland., Gatsonis C; Brown University School of Public Health - Center for Biostatistics and Health Data Science, Providence, RI, USA., Jacene H; Dana-Farber/Brigham Cancer Center, Boston, MA, USA., Connolly RM; Cancer Research @UCC, College of Medicine & Health, University College Cork, Cork, Ireland.; Cancer Trials Cork, CUH/UCC Cancer Center, Cork University Hospital, Cork, Ireland., Burnette BL; Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, USA., Stringer-Reasor EM; University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL, USA., Romanoff J; Brown University School of Public Health - Center for Biostatistics and Health Data Science, Providence, RI, USA., Taurone A; Brown University School of Public Health - Center for Biostatistics and Health Data Science, Providence, RI, USA., O'Sullivan CC; Mayo Clinic, Rochester, MN, USA., Le-Petross HT; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stearns V; John Hopkins University/Sidney Kimmel Cancer Center, Baltimore, MD, USA., Fowler AM; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Tang SC; Louisiana State University Health Sciences Center, New Orleans, LA, USA., Sepulveda KA; Baylor College of Medicine, Houston, TX, USA., DeMichele AM; University of Pennsylvania/Abramson Cancer Center, Philadelphia, PA, USA., Mankoff DA; University of Pennsylvania/Abramson Cancer Center, Philadelphia, PA, USA., Wolff AC; John Hopkins University/Sidney Kimmel Cancer Center, Baltimore, MD, USA. |
| Source: | Future oncology (London, England) [Future Oncol] 2025 Nov; Vol. 21 (26), pp. 3377-3384. Date of Electronic Publication: 2025 Oct 05. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41047708 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hennessy+MA%22">Hennessy MA</searchLink>; Cancer Research @UCC, College of Medicine & Health, University College Cork, Cork, Ireland.<br /><searchLink fieldCode="AU" term="%22Gatsonis+C%22">Gatsonis C</searchLink>; Brown University School of Public Health - Center for Biostatistics and Health Data Science, Providence, RI, USA.<br /><searchLink fieldCode="AU" term="%22Jacene+H%22">Jacene H</searchLink>; Dana-Farber/Brigham Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Connolly+RM%22">Connolly RM</searchLink>; Cancer Research @UCC, College of Medicine & Health, University College Cork, Cork, Ireland.; Cancer Trials Cork, CUH/UCC Cancer Center, Cork University Hospital, Cork, Ireland.<br /><searchLink fieldCode="AU" term="%22Burnette+BL%22">Burnette BL</searchLink>; Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Stringer-Reasor+EM%22">Stringer-Reasor EM</searchLink>; University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Romanoff+J%22">Romanoff J</searchLink>; Brown University School of Public Health - Center for Biostatistics and Health Data Science, Providence, RI, USA.<br /><searchLink fieldCode="AU" term="%22Taurone+A%22">Taurone A</searchLink>; Brown University School of Public Health - Center for Biostatistics and Health Data Science, Providence, RI, USA.<br /><searchLink fieldCode="AU" term="%22O'Sullivan+CC%22">O'Sullivan CC</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Le-Petross+HT%22">Le-Petross HT</searchLink>; University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Stearns+V%22">Stearns V</searchLink>; John Hopkins University/Sidney Kimmel Cancer Center, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fowler+AM%22">Fowler AM</searchLink>; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Tang+SC%22">Tang SC</searchLink>; Louisiana State University Health Sciences Center, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Sepulveda+KA%22">Sepulveda KA</searchLink>; Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22DeMichele+AM%22">DeMichele AM</searchLink>; University of Pennsylvania/Abramson Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Mankoff+DA%22">Mankoff DA</searchLink>; University of Pennsylvania/Abramson Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Wolff+AC%22">Wolff AC</searchLink>; John Hopkins University/Sidney Kimmel Cancer Center, Baltimore, MD, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101256629%22">Future oncology (London, England)</searchLink> [Future Oncol] 2025 Nov; Vol. 21 (26), pp. 3377-3384. <i>Date of Electronic Publication: </i>2025 Oct 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8301 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214796694%22">14796694 </searchLink><i>NLM ISO Abbreviation: </i>Future Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41047708 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/14796694.2025.2567840 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3377 Titles: – TitleFull: EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hennessy MA – PersonEntity: Name: NameFull: Gatsonis C – PersonEntity: Name: NameFull: Jacene H – PersonEntity: Name: NameFull: Connolly RM – PersonEntity: Name: NameFull: Burnette BL – PersonEntity: Name: NameFull: Stringer-Reasor EM – PersonEntity: Name: NameFull: Romanoff J – PersonEntity: Name: NameFull: Taurone A – PersonEntity: Name: NameFull: O'Sullivan CC – PersonEntity: Name: NameFull: Le-Petross HT – PersonEntity: Name: NameFull: Stearns V – PersonEntity: Name: NameFull: Fowler AM – PersonEntity: Name: NameFull: Tang SC – PersonEntity: Name: NameFull: Sepulveda KA – PersonEntity: Name: NameFull: DeMichele AM – PersonEntity: Name: NameFull: Mankoff DA – PersonEntity: Name: NameFull: Wolff AC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2025 Nov Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1744-8301 Numbering: – Type: volume Value: 21 – Type: issue Value: 26 Titles: – TitleFull: Future oncology (London, England) Type: main |
| ResultId | 1 |